文献速递心外重症与机械循环支持

从「血流动力学模型」迈向「机制性改善疾病模型」的心源性休克

Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock.
PubMed 文献 · J Heart Lung Transplant · 2018-07-17

文章指出短期机械增加心输出量虽改善血流动力学,但未必持续降低心源性休克患者死亡率。作者认为存在不同分子与生理休克内表型,血流动力学异常是触发因素而非主要结局驱动因素,提议建立「机制性改善疾病模型」以降低该人群停滞的死亡率。

要点

  • 短期机械增加心输出量改善血流动力学但未必持续降低死亡率
  • 心源性休克存在不同分子与生理内表型
  • 血流动力学异常是触发因素而非主要结局驱动因素

核心结论

  • 从血流动力学模型转向机制性改善疾病模型可能有助于降低心源性休克患者停滞的死亡率。

主要发现

  • 短期机械增加心输出量虽改善血流动力学,但未必持续改善心源性休克患者死亡率。
  • 心源性休克患者中可能存在不同的分子与生理休克内表型。
  • 血流动力学异常是触发因素,但不一定是临床结局的主要驱动因素。

临床怎么用

  • 在关注血流动力学改善之外,应重视心源性休克的分子与生理内表型及系统反应调控。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Emerging clinical evidence has suggested that short-term mechanical augmentation of cardiac output (CO) may not consistently improve mortality in patients with cardiogenic shock (CS), despite improvements in hemodynamics. Such failures could reflect the underlying complexity of the mechanisms that contribute to malperfusion and organ dysfunction in CS. Distinct molecular and physiologic shock endophenotypes likely exist among patients with CS, with hemodynamic aberrations as the inciting insult but not necessarily the primary drivers of clinical outcomes. We propose that building a framework that moves away from the current "hemodynamic model" in preference for a "mechanistic disease-modifying model" of CS may facilitate progress toward reducing the stagnant mortality rates in this population. Such a therapeutic paradigm shift in patients with chronic systolic heart failure-the shift away from strategies that augment CO to those that modulate the systemic responses to low CO-has been one of the single most important shifts in contemporary cardiovascular medicine.

来源:J Heart Lung Transplant,查看原文。版权归原作者所有。

引用

  1. Lawler PR, Mehra MR. Advancing from a "hemodynamic model" to a "mechanistic disease-modifying model" of cardiogenic shock. J Heart Lung Transplant. 2018. PMID: 30197209. doi:10.1016/j.healun.2018.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。